Breast Cancer
Hall 4
W ednesday: 13:30 - 15:30
|
2310.
|
MRI Correlates of Induration in the Irradiated Breast
Anwar R Padhani1, John Yarnold1, Jane Regan1, Janet E Husband1
1Institute of Cancer Research, Sutton, Surrey, UK.
|
|
2311.
|
Can Magnetic Resonance Mammography of Radial Scars Reduce Benign Biopsy Rates?
David John Manton1, Lindsay W. Turnbull1
1Hull Royal Infirmary, Hull, UK.
|
|
2312.
|
Comparison of the Characteristics of Node Negative and Positive Breast Cancers Measured by Dynamic Contrast Enhanced MRI with Three Analysis Methods
M. Y. Su1, Y. C. Cheung2, J. P. Fruehauf3, H. Yu1, J. Y. Chiou1, E. Mechetner3, S. S. Chen2, O. Nalcioglu1, Y. L. Wan2
1University of California, Irvine, CA, USA; 2Chang Gung Memorial Hospital, Linkou, Taiwan; 3Oncotech Inc., Irvine, CA, USA.
|
|
2313.
|
Combined Use of Dynamic Contrast Enhancement MRI, 1H MRS, and Perfusion MRI Improves Specificity in Detection of Breast Malignancy
Terry M. Button1, Khaldoon Al Dulaimy1, B. Kandel1, Paul A. Fisher1, B. O'Hea1, M. Kemeny1, Christine Geronimo1, V. Geronimo1, Wei Huang1
1State University of New York at Stony Brook, Stony Brook, NY, USA.
|
|
2314.
|
Comparative Analysis of Dynamic Contrast-Enhanced T1-Weighted and T2*-Weighted Perfusion Magnetic Resonance Imaging (MRI) in Patients with Breast Lesions. Preliminary Study.
Erica Endo1, Su Jin Kim1, Maria Concepcion Garcia Otaduy1, Luciano Fernandes Chala1, Antonio Carlos Nisida1, Jose Aristodemo Pinotti1, Claudia da Costa Leite1, Claudio Campi de Castro1, Nestor de Barros1, Giovanni Guido Cerri1
1University of Sao Paulo, Sao Paulo, SP Brazil.
|
|
2315.
|
Phyllodes Tumor of the Breast: MR Imaging Features with Pathologic Correlation
Keiko Kishimoto1, Katsuyoshi Ito1, Nobuhiko Ogasawara1, Masayasu Yasui1, Shinji Koike1, Hisato Kobayashi2, Naofumi Matsunaga1
1Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan; 2Otsu Red-Cross Hospital, Otsu, Shiga, Japan.
|
|
2316.
|
MRI Assessment of Breast Cancer Invasion: Skin and Chest Wall
Paul T. Weatherall1, R. Scott Goodwin1, Gregory Evans1, Jerri Payne1, Gregory Metzger1, M. Hossein Saaborian1, Tamara Campbell1, George Peters1
1University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
|
|
2317.
|
High Resolution Spiral Imaging of Breast Cancer
Lara Stables1, Bruce L. Daniel1, Gary H. Glover1, Robert J. Herfkens1
1Stanford University, Stanford, CA, USA.
|
|
2318.
|
Optimization of Imaging Parameters and Contrast Agent Dose for Dynamic Contrast-Enhanced MR Imaging of the Breast
Qing Yuan1, Sarah Englander1, Mitchell Schnall1
1University of Pennsylvania, Philadelphia, PA, USA.
|
|
2319.
|
Gadobenate dimeglumine (MultiHance®) in Magnetic Resonance Mammography (MRM)
Michael Knopp1, Michael Bourne2, Francesco Sardanelli3, Martin Wasser4, Isabella Salerio5, Anna La Noce5, Miles Andrew Kirchin5
1National Institutes of Health, Bethesda, MD, USA; 2University Hospital of Wales, Cardiff, Wales, England, UK; 3Biomedical SpA, Genova, Italy; 4Department of Radiology, Leiden, Netherlands; 5Bracco S.p.A., Milan, Italy.
|
|
2320.
|
Assessing the Value of Early MR Measurements for Predicting Response to Neoadjuvant Treatment in Locally Advanced Breast Cancer
Savannah C Partridge1, Laura J Esserman2, David C Newitt1, Nola M Hylton1
1University of California, San Francisco, San Francisco, CA, USA.
|
|
2321.
|
A 3D Technique to Determine Global Contrast Pharmacokinetics and Parenchyma Volume in Breast
Sarah Englander1, Qing Yuan1, Mitchell Schnall1
1University of Pennsylvania, Philadelphia, PA, USA.
|
|
2322.
|
Choline-Containing Compounds Can be Detected with a Choline-Specific Sequence and CSI in Breast Tissue
Tore Skjetne1, Inger Johanne Bakken1, Ingrid Gribbestad1
1SINTEF Unimed, Trondheim, Norway.
|
|
2323.
|
Comparison of In Vivo and In Vitro 1H MR Spectroscopy of Breast Cancer
Sandeep Hunjan1, Daniel Spielman1, Anne Sawyer-Glover1, Debra M. Ikeda1
1Stanford University, Stanford, CA, USA.
|
|
2324.
|
The Fractal Dimension of the Elasticity Tensor in MR-Elastography for the Differential Diagnosis of Breast Tumors
Ralph Sinkus1, Joern Lorenzen2, Dana Schrader3, Christoph Leussler1, Michael Dargatz1, Peter Roeschmann1
1Philips Research Laboratories, Hamburg Germany; 2Radiologische Klinik Eppendorf, Hamburg Germany; 3Frauenklinik Krankenhaus Eppendorf, Hamburg Germany.
|
|
2325.
|
Diagnostic Efficacy of Pre-operative Contrast-enhanced Breast MRI
Shih-chang Wang1, Bruno Mario Giuffré2, Steven Blome2, Jeanette Philips2, Marjorie B. Kossoff2
1National University of Singapore, National University Hospital, Singapore, Singapore; 2Royal North Shore Hospital, St. Leonards, NSW, Australia.
|
|
2326.
|
Comparison of Apparent Diffusion Coefficient (ADC) with Histologic Cellularity in Breast Tumors
Yong Guo1, Fulin Wang2, Youquan Cai2, Yuangui Gao2
1Naval General Hospital, Beijing, P.R.China; 2P.L.A General Hospital, Beijing, China.
|
|
2327.
|
Lactate Detection in Human Breast Cancer on 2.1T MR System
Pavel Shkarin1, Qiuhong He2
1Yale University, School of Medicine, New Haven, CT, USA; 2Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
|
|
2328.
|
Proton Spectroscopic Imaging of Breast Cancer
Daniel Spielman1, Sandeep Hunjan1, Anne Sawyer-Glover1, Elfar Adalsteinsson1, Debra M. Ikeda1
1Stanford University, Stanford, CA, USA.
|
|
2329.
|
Breast MRI in Clinical Practice - Five Year Retrospective
Frederick Kelcz1, Pamela A. Propeck1, Katherine A. Bueschel1
1University of Wisconsin-Madison, Madison, WI, USA.
|
|
2330.
|
Volume Localized 2D 1H COSY in Human Breast Cancer In Vivo
Kenneth Yue1, Nader Binesh1, Nanette Debruhl1, Albert Michael Thomas1
1University of California, Los Angeles, CA, USA.
|
|
2331.
|
Perfusion and Diffusion Contributions to ADC: Application to Breast Tumors In Vivo.
Shantanu Sinha1, Usha Sinha1, Flora Lucas-Quesada1, Nanette Debruhl1, Sarah Englander2, Mitchell Schnall2
1University of California, Los Angeles, Los Angeles, CA, USA; 2University of Pennsylvania, Philadelphia, PA, USA.
|
|
2332.
|
Characterization of Benign and Malignant Breast Lesions Using 1H MRS at 4 Tesla
Eva H Baker1, Lance DelaBarre1, Patrick J Bolan1, Hellmut Merkle1, Douglas Yee1, Lenore I Everson1, Michael Garwood1
1University of Minnesota, Minneapolis, MN, USA.
|
|
2333.
|
Dynamic Contrast-Enhanced MR Imaging Used to Evaluate Response of Neoadjuvant Chemotherapy of Breast Cancer
Kjell Kvistad1, Jana Rydland1, Hanne Brit Smethurst1, Ingrid S Gribbestad2, Gunnar Nilsen1, Steinar Lundgren1, Hans E Fjøsne1, Olav Haraldseth3
1University Hospital, Trondheim, Norway; 2SINTEF Unimed, Trondheim, Norway; 5Norwegian University of Science and Technology, Trondheim, Norway.
|
|
2334.
|
An Anthropomorphic Breast Phantom for MRI and Mammography
D. B. Plewes1, M. J. Yaffe1, S. J. Graham1, L. Little1, C. L. Nangini1, J. G. Mainprize1
1University of Toronto, Toronto, ON, Canada.
|
Prostate Cancer
Hall 4
Wednesday: 13:30 - 15:30
|
2335.
|
Resonance Peaks Exhibited in the Upper Field of Citrate on Proton MR Spectra of the Prostate - Assignments and Pathological Correlation -
Keiko Imamura1, Tatsuya Chikaraishi1, Akio Kazama1, Ichirou Tani1, Azuma Hashimoto1, Teruaki Iwamoto1, Hideo Atari1, Yasuo Nakajima1
1St. Marianna University, School of Medicine, Kawasaki, Kanagawa Japan.
|
|
2336.
|
1H HR-MAS Investigation of Four Potential Markers for Prostate Cancer.
Mark G. Swanson1, Daniel B. Vigneron1, Joyce K. James2, John Kurhanewicz1
1University of California, San Francisco, San Francisco, CA, USA; 2Bruker Instruments, Fremont, CA, USA.
|
|
2337.
|
Endorectal 2D L-COSY of Citrate, Spermine, Choline and Lipids in Human Prostate In Vivo
Nader Binesh1, Alan Marumoto1, Albert Thomas1, Kenneth Yue1, Jean Dekernion1, Zoran Barbaric1
1University of California, Los Angeles, Los Angeles, CA, USA.
|
|
2338.
|
Prostate Cancer Pathology: Statistical Classification Strategy Applied to Ex Vivo Proton MR Spectra
Roger Bourne1, Ray L. Somorjai2, Peter Russell1, Peter Swindle1, Simon Mccredie1, Philip Katelaris3, Susan Dowd1, Carolyn Mountford1
1University of Sydney, Sydney, NSW, Australia; 2National Research Council, Winnipeg, Manitoba, Canada; 3Sydney Adventist Hospital, Wahroonga, Sydney, Australia.
|
|
2339.
|
Assessment of the Sensitivity and Specificity of In Vivo Proton MRS using External Surface Coil in Differentiating Malignant from Normal Prostatic Tissue
Mahesh Kumar1, Rajeev Kumar1, A. K. Hemal1, N. R. Jagnnathan1
1All India Institute of Medical Sciences, New Dehli, India.
|
|
2340.
|
Characterization of Prostate Deformation during MR Examination Using Endorectal Coil for Accurate Localization of Tumor during Brachytherapy
Katrina Read1, Keyanoosh Hosseinzadeh1, Steven J DiBiase1, Rao P Gullapalli1
1University of Maryland, Baltimore, Baltimore, MD, USA.;
|
|
2341.
|
Dynamic Contrast-Enhanced MR Imaging of the Prostate: Correlation with Tumour Stage, Histological Grade and PSA.
Bin Wang1, Martin Lowry1, Lindsay Wilson Turnbull1
1University of Hull, Hull Royal Infirmary, Hull, England, UK.
|
|
2342.
|
Quantitative Maps of ADC and Time Course T2 of Human Prostate Xenograft Model in Athymic Nude Mice
Geon-Ho Jahng1, Song Lai1, Jiongjiong Wang1, Lahmer Lynds1, Gale R. Ramsby1, QiaoQiao Wang1, Kevin P. Claffey1
1University of Connecticut Health Center, Farmington, CT, USA.
|
|
2343.
|
Combined Use of Diffusion-Weighted Imaging (DWI) and MR Spectroscopic Imaging (MRSI) in the Detection of Prostate Cancer for Disease-Targeted Therapy
Keya Hosseinzadeh1, Katrina Read1, Steven DiBiase1, Rao Gullapalli1
1University of Maryland, Baltimore, Baltimore, MD, USA.
|
Other Cancers
Hall 4
Wednesday: 13:30 - 15:30
|
2344.
|
Dynamic contrast-enhanced MR Imaging and Tumour Oxygenation Measurements in Cervical Cancer
Susan M Todd1, Andrew P Jones1, Rachel A Cooper2, Julie A Loncaster2, Catherine M L West2, Johnathan R Sykes1, Bernadette M Carrington1
1Christie Hospital, Manchester, UK; 2Paterson Institute for Cancer Research, Manchester, UK;
|
|
2345.
|
Grading of Head and Neck Tumors by 1H MRS: An Approach with Potential Clinical Utility
Tedros Bezabeh1, S. El-Sayed2, O. Odlum2, S.I. Ahing2, R. Patel1, R. W. Nason2, D. Sutherland2, Ian Cormack Palmer Smith2
1National Research Council of Canada, Winnipeg, MB, Canada; 2University of Manitoba, Winnipeg, MB, Canada.
|
|
2346.
|
Phase III Safety and Efficacy Study of Ferumoxtran-10 as an MR Contrast Agent for the Evaluation of Lymph Node Metastasis in the Neck and Body
Yoshimi Anzai1, Laurie Loevner2, David M. Yousem3, Thomas McCauley4, Therese Weber5, Kenneth Maravilla1, Marie Morris6
1University of Washington, School of Medicine, Seattle, WA, USA; 2University of Pennsylvania, Philadelphia, PA, USA; 3Johns Hopkins University, School of Medicine, Baltimore, MD, USA; 4Yale University, New Haven, CT, USA; 5University of Alabama, Birmingham, AL, USA; 6Ad, Princeton, NJ, USA.
|
|
2347.
|
Evaluation of Thyroid Masses Using In Vivo 1H MR Spectroscopy: Correlation with Pathology
Wei Huang1, Patricia Roche1, Maisie Shindo1, Terry M. Button1
1State University of New York at Stony Brook, Stony Brook, NY, USA.
|
|
2348.
|
1H MRS of Soft Tissue Sarcoma: A New Approach Towards Improved Diagnosis
Tedros Bezabeh1, S. El-Sayed2, R. Patel1, Rajmund Somorjai1, Ian Cormack Palmer Smith2
1National Research Council of Canada, Winnipeg, MB Canada; 2University of Manitoba, Winnipeg, MB, Canada.
|
|
2349.
|
31P MRS of Phospholipids' Extracts from Blast Cells of Patients with Acute Leukaemia - Significance of Sphingomyelin
Malgorzata Kuliszkiewicz-Janus1, Stanislaw Baczynski2, Anna Jurczyk1, Iwona Prajs1, Bozena Jazwiec1
1Wroclaw Medical University, Wroclaw, Poland; 2University of Wroclaw, Wroclaw, Poland.
|
|
2350.
|
Rapid Proton Fat-Water Spectroscopy for the Characterization of Non-CNS Lesions In Vivo
Gerard Riedy1
1Wake Forest University, Bowman-Grey Medical Center, Winston-Salem, NC, USA.
|
|
2351.
|
Evaluation of Ovarian Tumors by Quantitative In Vivo Proton MR Spectroscopy
Toshiko Okada1, Masafumi Harada1, Kenji Matsuzaki1, Hiromu Nishitani1, Toshihiro Aono1
1University of Tokushima, Tokushima, Japan.
|
Share with your friends: |
